These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31300265)

  • 1. Transfusing children with hemoglobinopathies.
    Allali S; Taylor M; Albinni S; Amiranoff D; de Montalembert M
    Transfus Clin Biol; 2019 Sep; 26(3):147-149. PubMed ID: 31300265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in sickle cell disease treatments: Towards targeted therapies].
    Arlet JB
    Rev Med Interne; 2020 Feb; 41(2):73-77. PubMed ID: 31771774
    [No Abstract]   [Full Text] [Related]  

  • 3. [Potential alternatives to erythrocyte transfusion in hemoglobinopathies: hydroxyurea (HU), erythropoietin (EPO), butyrate derivatives, blood substitutes].
    Bachir D; Galacteros F
    Transfus Clin Biol; 1994; 1(1):35-9. PubMed ID: 8186851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease.
    Ferraresi M; Panzieri DL; Leoni S; Cappellini MD; Kattamis A; Motta I
    Eur J Pediatr; 2023 Jun; 182(6):2509-2519. PubMed ID: 36997768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
    Sii-Felice K; Giorgi M; Leboulch P; Payen E
    Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies.
    Yesilipek MA
    Hemoglobin; 2020 Nov; 44(6):377-384. PubMed ID: 33050763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Options for Sickle Cell Disease.
    Meier ER
    Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of hematopoietic stem cell transplantation in hemoglobinopathies: thalassemia major and sickle cell disease].
    Hladun R; Elorza I; Olivé T; Dapena JL; Llort A; Sánchez de Toledo J; Díaz de Heredia C
    An Pediatr (Barc); 2013 Aug; 79(2):75-82. PubMed ID: 23402775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion support for haemoglobinopathies.
    Greenwalt TJ; Zelenski KR
    Clin Haematol; 1984 Feb; 13(1):151-65. PubMed ID: 6373080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
    Horan JT; Liesveld JL; Fenton P; Blumberg N; Walters MC
    Bone Marrow Transplant; 2005 Jan; 35(2):171-7. PubMed ID: 15531901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion Therapy in Children With Sickle Cell Disease.
    Inati A; Mansour AG; Sabbouh T; Amhez G; Hachem A; Abbas HA
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):126-132. PubMed ID: 27509379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N; Papayanni PG; Yannaki E
    Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease.
    Leonard A; Tisdale JF; Bonner M
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):769-795. PubMed ID: 35773052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythrocyte transfusions in hemoglobinopathies: indications].
    Galacteros F
    Transfus Clin Biol; 1994; 1(1):15-7. PubMed ID: 8186847
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the Treatment of Sickle Cell Disease.
    Kapoor S; Little JA; Pecker LH
    Mayo Clin Proc; 2018 Dec; 93(12):1810-1824. PubMed ID: 30414734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell transplantation in hemoglobinopathies.
    Yesilipek MA
    Hemoglobin; 2007; 31(2):251-6. PubMed ID: 17486508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
    Leonard A; Bertaina A; Bonfim C; Cohen S; Prockop S; Purtill D; Russell A; Boelens JJ; Wynn R; Ruggeri A; Abraham A
    Cytotherapy; 2022 Mar; 24(3):249-261. PubMed ID: 34879990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allogeneic hematopoietic stem cell transplant in children and adults with sickle cell disease: Indications and modalities].
    Dhédin N; Paillard C; Dalle JH; Ouachée M; Buchbinder N; Brissot E; Beguin Y; Masouridi-Levrat S; Yakoub-Agha I; Bernit E; Pondarre C
    Bull Cancer; 2020 Sep; 107(9):925-933. PubMed ID: 32921398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
    Payen E; Leboulch P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.